BPA Call 36C24124A0014-36C24126N0901
Award Date 9/10/26
Potential Completion Date 9/9/27
Potential Value $6.6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02451, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 7 issued a delivery order to Exosome Diagnostics Inc. on April 1, 2026, for ExoDx Prostate testing with a ceiling value of $447,905.92, under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Place of performance is Augusta, GA. The order extends through March 31, 2031. Exosome Diagnostics provides ExoDx Prostate (IntelliScore), a non-invasive, urine-based liquid biopsy test that analyzes exosomal RNA biomarkers to...
- Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a $69,891.36 firm fixed-price task order from the Department of Veterans Affairs Veterans Integrated Service Network 1 (VISN 1) for ExoDx Prostate IntelliScore testing services. This contract, awarded January 15, 2024, with completion by December 14, 2024, represents a child task order issued against the company's parent Blanket Purchase Agreement valued at $1.35M. The ExoDx Prostate...
- This is a Year 3 task order issued against a parent Blanket Purchase Agreement (BPA) held by Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation specializing in advanced liquid biopsy diagnostic technologies. The task order, valued at $270K and awarded December 15, 2025, by Veterans Integrated Service Network 1 (VISN 1) under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), will deliver approximately 360 ExoDx Prostate IntelliScore tests...
- Veterans Integrated Service Network 2 issued a delivery order to Exosome Diagnostics Inc. on October 1, 2024, with a ceiling value of $384,026.72 for ExoDx Prostate IntelliScore biopsies at Northport VA Medical Center. The order is issued under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), a governmentwide vehicle supporting laboratory diagnostic testing and analysis services. Performance occurs at Northport, NY, with an ultimate completion date...
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, received a Blanket Purchase Agreement (BPA) call valued at $103,709.76 from Veterans Integrated Service Network 1 (VISN 1), a component of the Department of Veterans Affairs. The award, issued on December 15, 2024, is for the provision of ExoDx Prostate IntelliScore testing services, a non-invasive, urine-based liquid biopsy diagnostic test that analyzes exosomal RNA biomarkers to assess the risk of clinically significant prostate...
- Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a delivery order award from Veterans Integrated Service Network (VISN) 7 on April 1, 2021, for its ExoDx Prostate (IntelliScore) diagnostic testing services. The delivery order, valued at $438,951.68 on a firm fixed-price basis, is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not utilize a set-aside designation. Performance...
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, was awarded a $692,149.52 firm fixed-price delivery order by Veterans Integrated Service Network 6 (VISN 6) on May 13, 2022, for the provision of ExoDx Prostate (IntelliScore) testing services. The contract, which is a child award under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), requires performance through September 30, 2026, at the Richmond, VA location. This non-invasive,...
- This is a $8,266.72 firm fixed price delivery order contract awarded to Exosome Diagnostics, Inc., a subsidiary of Bio-Techne Corporation, by the U.S. Department of Veterans Affairs (VA). The contract is for the provision of the ExoDx Prostate (IntelliScore) non-invasive, urine-based liquid biopsy test to support prostate cancer screening for veterans at the Northport VA Medical Center. This contract was awarded under the VA's Medical Laboratory Testing and Analysis Services Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, a $0.00 firm fixed price delivery order against the Medical Laboratory Testing and Analysis Services (FSS-621-II) GSA Schedule. The order is for EXO DX OPTION YR 1 services with a period of performance through September 30, 2022. No set-aside designation was used for this award. Exosome Diagnostics will provide...
- This federal contract award is for the EXOSOME DX TESTING service provided by Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. The $37,576.00 firm-fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) under the Medical Laboratory Testing and Analysis Services GSA Schedule contract. The contract supports the VA's prostate cancer screening initiatives for veterans, with Exosome Diagnostics supplying its ExoDx Prostate IntelliScore liquid biopsy test,...